Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors

NCT02038738 is registered in ClinicalTrials.gov with Ochsner Health System as lead sponsor.

NCT NCT02038738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02038738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors
Lead sponsor
Ochsner Health System
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 2014
Completion date
Not reported
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

apudoma, carcinoid, carcinoid tumor, islet cell tumor, neuroendocrine, neuroendocrine cancer, neuroendocrine carcinoma, neuroendocrine tumor